Back to results
US 12,624,008 B2Granted
4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid as an inducer of Z A1AT secretion for treating AATD
AssigneeCentessa Pharmaceuticals (UK) Limited
InventorsNigel Ramsden, David John Fox, James Andrew Huntington
Life of this patent
Estimating the term…
Abstract
The invention relates to 4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid, compositions thereof, and uses of either, for example in the treatment of α1-antitrypsin deficiency (A1AD or AATD).
Claims4
A method of treating α1-antitrypsin deficiency (AATD) in a subject in need thereof, the method comprising administering to the subject in need thereof a compound represented by the structure of
- or a pharmaceutically acceptable salt thereof;
- or
- a pharmaceutical composition comprising a compound represented by the structure of
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
1 more element
Dependencies are inferred from the claim text.